Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- CHF | -.--% | -.--% | -.--% |
22/05 | UBS Starts Colruyt Coverage With Buy Rating | MT |
22/05 | Colruyt: in the green on broker's comments | CF |
Sales 2024 * | 10.81B 11.69B 10.68B 973B | Sales 2025 * | 11.49B 12.43B 11.36B 1,035B | Capitalization | 5.84B 6.32B 5.77B 526B |
---|---|---|---|---|---|
Net income 2024 * | 553M 598M 547M 49.79B | Net income 2025 * | 349M 377M 345M 31.42B | EV / Sales 2024 * | 0.57 x |
Net Debt 2024 * | 285M 308M 282M 25.66B | Net Debt 2025 * | 338M 366M 334M 30.47B | EV / Sales 2025 * | 0.54 x |
P/E ratio 2024 * |
6.3
x | P/E ratio 2025 * |
15.7
x | Employees | - |
Yield 2024 * |
4.94% | Yield 2025 * |
3.15% | Free-Float | 24.23% |
Managers | Title | Age | Since |
---|---|---|---|
Stefan Goethaert
CEO | Chief Executive Officer | - | 01/12/01 |
Stefaan Vandamme
DFI | Director of Finance/CFO | - | 01/19/01 |
Jef Colruyt
CHM | Chairman | - | 01/94/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Rika Coppens
BRD | Director/Board Member | 52 | 31/19/31 |
Director/Board Member | 60 | 01/11/01 | |
Jef Colruyt
CHM | Chairman | - | 01/94/01 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+23.39% | 526B | |
+16.63% | 38.91B | |
-0.36% | 36.22B | |
+21.80% | 34.76B | |
+7.50% | 27.58B | |
-15.30% | 25.4B | |
+18.41% | 18.85B | |
+5.78% | 18.25B | |
+4.91% | 14.59B |
- Stock Market
- Equities
- COLR Stock
- COLR Stock